fbpx

molecules of the month

CG428

CRBN-based TRK kinase fusion prot. degrader

degrad. of mult. TRK fusions (e.g. TPM3-TRKA)

from functionalization of lit. TRK inhibitor

J. Med. Chem., Oct. 15, 2020

Cullgen Inc., San Diego, CA / Shanghai, CN

Structure of CG428
1 min read

CG428 (Cullgen CRBN-based TRK kinase fusion protein degrader)


request a trial

Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.

Request a trial to access insights powering the pros in our industry.


already a member? log in: